Announced
Completed
Synopsis
Avidity Partners, an investment company, led a $200m funding round in NeoGenomics, a network of clinical laboratories that specializes in cancer genetics diagnostic testing services. Additional investors include Farallon Capital Management, RS Investments, Casdin Capital, Driehaus Capital, Pura Vida Investments, RTW Investments, Janus Henderson Investors, Federated Hermes Kaufmann Fund, Soleus Capital, Blue Water Life Science Fund, Woodline Partners and First Light Asset Management.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.